Bartter disease type 1: genes and variants
Bartter disease type 1 is linked to 2 analyzed proteins (CLCNKB and SLC12A1). 30 DNA variants are known to cause it; 248 more are uncertain, and 0 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Also known as: Bartter disease type 3; Bartter disease type 4B; Bartter disease type 5
Genes linked to Bartter disease type 1
CLCNKB: Chloride channel protein ClC-Kb
It supports chloride reabsorption in the thick ascending limb and distal nephron, helping establish salt balance and the kidney's concentrating gradient. Biallelic loss-of-function variants cause Bartter syndrome type 3 and can sometimes mimic Gitelman syndrome.
16 disease-causing and 87 uncertain variants in CLCNKB are linked to Bartter disease type 1.
SLC12A1: Solute carrier family 12 member 1
It reabsorbs sodium, potassium, and chloride in the thick ascending limb of the kidney, helping generate the medullary concentration gradient and maintain salt balance. Biallelic loss-of-function variants cause Bartter syndrome type 1 with renal salt wasting.
14 disease-causing and 158 uncertain variants in SLC12A1 are linked to Bartter disease type 1.
Weakly linked (only a few uncertain records): MAGED2.
Where Bartter disease type 1 variants cluster
- CLCNKB Transmembrane (positions 421–440): 6 of 16 disease-causing changes, 12.9× more than its size predicts.
- SLC12A1 Extracellular (positions 439–550): 6 of 14 disease-causing changes, 4.2× more than its size predicts.
- SLC12A1 Transmembrane (positions 551–571): 3 of 14 disease-causing changes, 11.2× more than its size predicts.
Known disease-causing variants in Bartter disease type 1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CLCNKB R438C | 438 | Transmembrane | Disease-causing (★★) |
| CLCNKB R438H | 438 | Transmembrane | Disease-causing (★★) |
| CLCNKB E442G | 442 | Disease-causing (★★) | |
| SLC12A1 E368G | 368 | Extracellular | Disease-causing (★★) |
| SLC12A1 A555T | 555 | Transmembrane | Disease-causing (★★) |
| CLCNKB G424R | 424 | Transmembrane | Disease-causing (★★) |
| CLCNKB G437R | 437 | Transmembrane | Disease-causing (★★) |
| CLCNKB L439P | 439 | Transmembrane | Disease-causing (★★) |
| SLC12A1 G257S | 257 | Cytoplasmic | Disease-causing (★★) |
| SLC12A1 R439Q | 439 | Extracellular | Disease-causing (★★) |
| SLC12A1 G478R | 478 | Extracellular | Disease-causing (★★) |
| SLC12A1 A498V | 498 | Extracellular | Disease-causing (★★) |
| SLC12A1 A508T | 508 | Extracellular | Disease-causing (★★) |
| CLCNKB P124L | 124 | Helical | Disease-causing (★★) |
| CLCNKB V170M | 170 | Transmembrane | Disease-causing (★★) |
| SLC12A1 C475Y | 475 | Extracellular | Disease-causing (★★) |
| SLC12A1 G612R | 612 | Transmembrane | Disease-causing (★★) |
| CLCNKB R92W | 92 | Transmembrane | Disease-causing (★★) |
| CLCNKB A204T | 204 | Helical | Disease-causing (★★) |
| CLCNKB R351W | 351 | Helical | Disease-causing (★★) |
| SLC12A1 A510D | 510 | Extracellular | Disease-causing (★) |
| SLC12A1 L560P | 560 | Transmembrane | Disease-causing (★) |
| CLCNKB E442K | 442 | Disease-causing (★) | |
| SLC12A1 A562V | 562 | Transmembrane | Disease-causing (★) |
| CLCNKB A467V | 467 | Helical | Disease-causing (★) |
| CLCNKB G470R | 470 | Helical | Disease-causing (★) |
| SLC12A1 V272F | 272 | Transmembrane | Disease-causing |
| CLCNKB A349D | 349 | Helical | Disease-causing |
| SLC12A1 E281D | 281 | Extracellular | Disease-causing |
| CLCNKB Y432H | 432 | Transmembrane | Disease-causing |
Which prediction tools work for Bartter disease type 1
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 98 out of 100
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 94 out of 100
- phyloP: 89 out of 100
Diseases related to Bartter disease type 1
- Bartter syndrome, also linked to CLCNKB and SLC12A1
- Nephrotic syndrome, also linked to SLC12A1
- Kidney disorder, also linked to SLC12A1
Frequently asked questions
Which genes are linked to Bartter disease type 1?
In CATVariant, Bartter disease type 1 is linked to 2 analyzed proteins: CLCNKB (Chloride channel protein ClC-Kb) and SLC12A1 (Solute carrier family 12 member 1).
How many genetic variants are linked to Bartter disease type 1?
321 variants: 30 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 248 are of uncertain significance or have conflicting reports.
Which uncertain variants in Bartter disease type 1 look disease-causing?
None of the uncertain variants currently reaches the likely-pathogenic range on computable evidence alone.
Which variant effect predictor works best for Bartter disease type 1?
Among tools not trained on clinical labels, CADD separates this disease's known disease-causing variants from harmless ones best (AUROC 0.98, based on 24 disease-causing and 43 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center